Epharmacy startup, PharmEasy announced another round of layoffs, months after its first. Actual number of employees impacted by the decision are not verified yet.
The majority of those affected worked in product technology, quality analytics, and support. Employees from the broader technology and design teams were also affected. Employees who were laid off were given a variety of reasons, including restructuring, macroeconomic headwinds, and the ongoing Russia-Ukraine war. PharmEasy is beset by a slew of problems, including mounting losses, a funding crunch, and postponed IPO plans.
Disclaimer
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
Epharmacy startup, PharmEasy announced another round of layoffs, months after its first. Actual number of employees impacted by the decision are not verified yet.
The majority of those affected worked in product technology, quality analytics, and support. Employees from the broader technology and design teams were also affected. Employees who were laid off were given a variety of reasons, including restructuring, macroeconomic headwinds, and the ongoing Russia-Ukraine war. PharmEasy is beset by a slew of problems, including mounting losses, a funding crunch, and postponed IPO plans.
Disclaimer
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
